APA (7th ed.) Citation

Yang, H. S., Hur, M., Lee, K. R., Kim, H., Kim, H. Y., Kim, J. W., . . . Di Somma, S. (2022). Biomarker Rule-in or Rule-out in Patients With Acute Diseases for Validation of Acute Kidney Injury in the Emergency Department (BRAVA): A Multicenter Study Evaluating Urinary TIMP-2/IGFBP7. Annals of laboratory medicine, 42(2), 178-187. https://doi.org/10.3343/alm.2022.42.2.178

Chicago Style (17th ed.) Citation

Yang, Hyun Suk, et al. "Biomarker Rule-in or Rule-out in Patients With Acute Diseases for Validation of Acute Kidney Injury in the Emergency Department (BRAVA): A Multicenter Study Evaluating Urinary TIMP-2/IGFBP7." Annals of Laboratory Medicine 42, no. 2 (2022): 178-187. https://doi.org/10.3343/alm.2022.42.2.178.

MLA (9th ed.) Citation

Yang, Hyun Suk, et al. "Biomarker Rule-in or Rule-out in Patients With Acute Diseases for Validation of Acute Kidney Injury in the Emergency Department (BRAVA): A Multicenter Study Evaluating Urinary TIMP-2/IGFBP7." Annals of Laboratory Medicine, vol. 42, no. 2, 2022, pp. 178-187, https://doi.org/10.3343/alm.2022.42.2.178.